- Home
- ARAY vs TIL Comparison
ARAY vs TIL Comparison
Compare ARAY & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- TIL
- Stock Information
- Founded
- ARAY 1990
- TIL 2018
- Country
- ARAY United States
- TIL United States
- Employees
- ARAY N/A
- TIL N/A
- Industry
- ARAY Medical/Dental Instruments
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- ARAY Health Care
- TIL Health Care
- Exchange
- ARAY Nasdaq
- TIL Nasdaq
- Market Cap
- ARAY 170.1M
- TIL 177.1M
- IPO Year
- ARAY 2007
- TIL 2021
- Fundamental
- Price
- ARAY $1.57
- TIL $24.10
- Analyst Decision
- ARAY Strong Buy
- TIL Buy
- Analyst Count
- ARAY 1
- TIL 6
- Target Price
- ARAY $5.00
- TIL $120.50
- AVG Volume (30 Days)
- ARAY 742.6K
- TIL 140.2K
- Earning Date
- ARAY 11-05-2025
- TIL 11-12-2025
- Dividend Yield
- ARAY N/A
- TIL N/A
- EPS Growth
- ARAY N/A
- TIL N/A
- EPS
- ARAY N/A
- TIL N/A
- Revenue
- ARAY $458,505,000.00
- TIL N/A
- Revenue This Year
- ARAY $5.84
- TIL N/A
- Revenue Next Year
- ARAY $3.90
- TIL N/A
- P/E Ratio
- ARAY N/A
- TIL N/A
- Revenue Growth
- ARAY 2.68
- TIL N/A
- 52 Week Low
- ARAY $1.14
- TIL $10.80
- 52 Week High
- ARAY $2.95
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- ARAY 56.74
- TIL 42.77
- Support Level
- ARAY $1.54
- TIL $22.67
- Resistance Level
- ARAY $1.64
- TIL $33.83
- Average True Range (ATR)
- ARAY 0.06
- TIL 2.45
- MACD
- ARAY -0.00
- TIL -0.55
- Stochastic Oscillator
- ARAY 57.89
- TIL 12.81
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.